Until vaccines against COVID-19 become available, ‘testing, testing and more testing’ to support the detection of cases and isolation of patients is the only effective strategy against the disease.
Kunal Jain, from IMAP India’s team, summarises the pharmaceutical progress on treatments for Covid-19 and highlights from a recent virtual conference on this subject in Israel the steps being taken across the world on a possible cure to halt the spread of the virus.
NCL Industries is a four-decade old public company that manufactures and sells building materials such as cement, ready mix concrete, cement bonded particle boards, and doors.
Apremeda is the exclusive distributor of Dr. Wolff products in the Czech and Slovak Republics
IMAP partners around the world closed 185 M&A deals worth more than $18 billion during the Q1-Q3 2021 period. The boom in market activity observed in the first half of the year continued in Q3 and indicators suggest that 2021 will close out as one the strongest years for IMAP on record.
